Changjiang Huang

Development of novel anti‐CD19 antibody‐drug conjugates for B‐cell lymphoma treatment

Jianmin Fang, Lina Liu, Xuejing Yao, 2018, International immunopharmacology.

An anti-HER2 antibody conjugated with monomethyl auristatin E is highly effective in HER2-positive human gastric cancer

L. Lou, Jianmin Fang, Xuejing Yao, 2016, Cancer biology & therapy.

HER2-targeted antibody drug conjugates for ovarian cancer therapy.

M. Huang, Jing Zhang, Xiuli Zhang, 2016, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

A novel anti-DR 5 antibody-drug conjugate possesses a high-potential therapeutic efficacy for leukemia and solid tumors

Chao Zheng, Shuyong Zhang, Dongdong Zhou, 2019 .

A novel humanized anti-HER2 antibody conjugated with MMAE exerts potent anti-tumor activity

L. Lou, Dong Li, Jianmin Fang, 2015, Breast Cancer Research and Treatment.

Monomethyl auristatin E-conjugated anti-EGFR antibody inhibits the growth of human EGFR-positive non-small cell lung cancer

Jianmin Fang, Wenting Luo, Xuejing Yao, 2019, Cancer Chemotherapy and Pharmacology.

AMG 655, a monoclonal antibody agonist directed against Death Receptor 5, induces apoptosis in human colon carcinoma cell lines and its therapeutic potential is enhanced in combination with chemotherapeutic agents

B. Gliniak, Justin N. Huard, Yang Pan, 2008 .

Development of a Novel EGFR-Targeting Antibody-Drug Conjugate for Pancreatic Cancer Therapy

Jianmin Fang, Wenting Luo, Xuejing Yao, 2019, Targeted Oncology.

A novel anti-DR5 antibody-drug conjugate possesses a high-potential therapeutic efficacy for leukemia and solid tumors

D. Zheng, Chao Zheng, Shuyong Zhang, 2019, Theranostics.